| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers B > Headlines for Bristol-Myers Squibb Co. > News item |
Bristol-Myers Squibb sells 71,625 shares of Celldex for 9.14% stake
By Lisa Kerner
Charlotte, N.C., Nov. 25 - Bristol-Myers Squibb Co. sold 71,625 shares of Celldex Therapeutics, Inc. on Nov. 23 and Nov. 24 priced at $4.92 and $4.75 each, respectively, according to a schedule 13D/A filed on Wednesday with the Securities and Exchange Commission.
In the filing, Bristol-Myers Squibb reported beneficial ownership of 2,889,223 shares, or 9.14%, of the Bloomsbury, N.J., biopharmaceutical company.
Bristol-Myers Squibb is a New York biopharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.